Featured Research

from universities, journals, and other organizations

HIV Screening Found Cost-effective In Older Adults

Date:
June 18, 2008
Source:
Duke University Medical Center
Summary:
Recent studies suggest that large numbers of Americans remain sexually active well into their 60's, 70's and even 80's. But researchers say seniors may be overlooked as possible carriers of the AIDS virus, and based on a new study, they are recommending screening for most adults ages 55 to 75 as a sensible, cost-effective way to prolong life, and decrease the spread of the disease.

Recent studies suggest that large numbers of Americans remain sexually active well into their 60's, 70's and even 80's. But researchers at Duke University Medical Center say seniors may be overlooked as possible carriers of the AIDS virus, and based on a new study, they are recommending screening for most adults ages 55 to75 as a sensible, cost-effective way to prolong life and decrease the spread of the disease.

"Many of us might think of HIV as associated with teens and younger adults, but statistics show that 19 percent of those infected were diagnosed at age 50 or older," says Gillian Sanders, Ph.D., associate professor of medicine at the Duke Clinical Research Institute and the lead author of the study appearing in the June 17 issue of the Annals of Internal Medicine.

The Centers for Disease Control recommends HIV screening for patients aged 13 to 64, and Sanders says it is clearly cost-effective to screen younger populations -- even if the prevalence of the disease is low -- because any benefits will be enjoyed over a much longer period. But HIV is less prevalent among older Americans. In addition, older patients are also more likely to have fewer sex partners and more life-threatening conditions that might make routine screening less economically attractive.

"Until now, we've assumed that screening made a lot of sense in younger people but we really didn't know if it was a good use of our healthcare resources in older folks," says Sanders. "That's why we needed to do this study."

Sanders worked with colleagues at Stanford University, the Veterans Affairs Palo Alto Health Care System and St. Michael's Hospital in Toronto in evaluating the cost-effectiveness of HIV screening among patients aged 55 to 74.

The authors used a computerized model that tracked older patients over their lifetime. The model noted whether the patients were screened or not, their HIV status, the clinical course of any HIV disease, the cost and consequences of any transmission and the cost and effects of treatment. They also took into account the likelihood of any age and gender-related issues that could shorten the patients' lives.

Cost-effectiveness is often measured in quality-adjusted life-years (QAYLs), a figure that takes into account numerous factors, including the quality of life and the length of life.

The authors noted that the cost-effectiveness of HIV screening was dependent on the prevalence of the disease, the age of the patient, the cost of counseling and whether the patient was sexually active.

Assuming that 0.5 percent of the study population were HIV-positive, the researchers found that HIV screening for patients aged 65 who were not sexually active would cost $55,440 per QALY gained, while screening for sexually-active 65 year olds would cost $30,020 per QALY. Sanders says such figures are within the range of other accepted cost-effective ratios, and in the United States, these would generally be considered "a good use of our healthcare dollars."

Based on case studies, they also found that screening and early diagnosis for a 65-year old HIV-infected patient could mean an extra half year of life, while for a 75-year old HIV-infected patient, it would mean an extra four months of life.

"This suggests that HIV screening for many older adults is indeed cost-effective, particularly for those who are sexually active," says Sanders, who says some of the newer, lower-cost, streamlined counseling formats might be particularly appropriate for this population.

"All of us also need to remember that age doesn't protect anyone from HIV. You're as vulnerable at 60 as you are at 16."

The study was funded by the Department of Veterans Affairs, the National Institute on Drug Abuse, the National Institute on Aging and the Ontario HIV Treatment Network.

The senior author of the study is Douglas Owens, a senior investigator at the VA Palo Alto Healthcare System and a professor of medicine at Stanford. Other co-authors are Mark Holodniy, also at the VA and a professor of medicine at Stanford, and Ahmed Bayoumi, a professor of medicine and health policy, management and evaluation, at the University of Toronto.


Story Source:

The above story is based on materials provided by Duke University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Duke University Medical Center. "HIV Screening Found Cost-effective In Older Adults." ScienceDaily. ScienceDaily, 18 June 2008. <www.sciencedaily.com/releases/2008/06/080616170756.htm>.
Duke University Medical Center. (2008, June 18). HIV Screening Found Cost-effective In Older Adults. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2008/06/080616170756.htm
Duke University Medical Center. "HIV Screening Found Cost-effective In Older Adults." ScienceDaily. www.sciencedaily.com/releases/2008/06/080616170756.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins